Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Oxytocin for Alcohol Craving
NCT03865615Phase 2Withdrawn
- Start
- Nov 2023
- Primary completion
- Apr 2024
- Countries
- 1
01
Overview
A Phase 2 trial of oxytocin nasal spray in alcohol use disorder (AUD). Planned start Nov 2023; status: withdrawn.
02
Drugs
oxytocin nasal spray
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT03865615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03865615.